The overwhelming majority of Chinese COVID vaccines have been sold to middle-income countries with only about 2% going to low-income states, according to new research by the China Power Project at the Center for Strategic Studies (CSIS) in Washington, D.C.
Since 90+% of Chinese vaccine distributions around the world have been in the form of sales, most of the world’s poorest countries simply don’t have the resources to procure vaccines from China.
Lead the Conversation on China
Subscribe Today to Get Full Access to The China-Global South Project
$19.00 / monthly
Cancel Anytime - Renews Monthly
$199.99 / yearly
Check Out Everything You'll Get With Your Subscription
The China-Global South Daily Brief delivered to your inbox at 6AM Washington time
Full access to exclusive news and analysis from editors based in the Global South
China’s ambassador to Ethiopia, Zhao Zhiyuan handed over a donation of 800,000 doses of Sinopharm COVID-19 vaccine on Sunday to Health Minister Lia Tadesse at a ceremony at the international airport ...